Fibrinogen Sevilla, a congenital dysfibrinogenemia characterized by an abnormal monomer aggregation and a defective plasmin lysis. 1989

F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
University Clinic of Navarra, Faculty of Medicine, Pamplona, Spain.

A dysfibrinogenemia (fibrinogen Sevilla) was detected in a 64-yr-old woman with no previous history of hemorrhagic diathesis or thrombosis. Thrombin and reptilase times were prolonged. The aggregation of fibrin monomers showed a prolonged latency time with a defective slope although fibrinopeptide release and clot stabilization were found to be normal. Plasmin proteolysis was abnormal with a much slower plasmic degradation in patient's purified fibrinogen. By chromatofocussing the patient's fibrinogen showed an abnormality in pattern elution with a second peak eluting at a pH slightly more basic than the normal one (pH 5.5). Likewise, the isoelectrofocussing of purified non-reduced patient's fibrinogen in agarose gel showed an abnormal distribution in its focussed bands, especially in a group which focussed in a pI-interval between 5.20-5.85. By two-dimensional electrophoresis we did not find any abnormality in the fibrinogen-reduced chains. These results could indicate that the abnormal monomer aggregation, as well as the defective plasmin lysis, could be due to conformational aspects of fibrinogen rather than to structural defects.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004586 Electrophoresis An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current. Electrophoreses
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015241 Fibrinogens, Abnormal Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. Abnormal Fibrinogens

Related Publications

F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
November 1985, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
March 1987, Thrombosis research,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
February 1985, Thrombosis research,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
June 1973, Thrombosis et diathesis haemorrhagica,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
July 2017, Haemophilia : the official journal of the World Federation of Hemophilia,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
November 1974, Pathologie-biologie,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
April 1985, Thrombosis research,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
March 1987, Thrombosis research,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
December 1999, Thrombosis and haemostasis,
F J Fernández, and P Noguerol, and R Sosa, and B Cuesta, and J A Páramo, and E Rocha
February 1969, The Journal of clinical investigation,
Copied contents to your clipboard!